DOYLESTOWN, Pa., Feb. 28, 2018 -- Alamo Pharma Services (“Alamo”) was recently recognized as one of Training magazine’s annual Training Top 125, that ranks companies’ excellence in employer-sponsored training and development programs. The rankings were unveiled during an awards gala held in conjunction with the recent Training 2018 Conference and Expo in Atlanta.
“Receiving this recognition from Training magazine, a true ‘go-to resource’ for all industries, is an exciting honor for the team at Alamo,” says Peter Marchesini, Chief Operating Officer of Alamo. “We’re tremendously proud of our training programs. It is gratifying to be saluted as one of the top training organizations in the country along with all of the other deserving winners.”
Training magazine, the leading business publication for Learning and Development professionals, has been releasing its Training Top 125 rankings for the past 18 years. The results are determined by assessing a range of qualitative and quantitative factors and benchmarking statistics including:
- Total training budget
- Percentage of payroll
- Number of training hours per employee program
- Goals, evaluation, measurement, and workplace surveys
- Hours of training per employee annually
- Detailed formal programs
“We salute the 2018 Training Top 125 winners’ fierce commitment to employee learning and development and their passionate belief that training matters,” says Lorri Freifeld, editor-in-chief of Training magazine. “These companies constantly look for innovative ways to effectively deliver and measure employee training, and they are rewarded with an engaged, passionate workforce and organizational success.”
About Alamo Pharma Services
Founded in 2011, Alamo Pharma Services offers pharmaceutical and biotech companies vital solutions to bring their products to market efficiently and successfully. Based out of its offices in Doylestown, Pa., Alamo offers companies vast commercialization experience, customized recruiting of sales teams, superior training, and committed support services. For more information regarding Alamo, visit www.AlamoPharmaServices.com or email [email protected].
Alamo is part of the Mission Family of Companies, a collection of wholly-owned subsidiaries created by Mission Pharmacal to diversify offerings and build forward-thinking partnerships with other pharmaceutical and biotech companies. Other Mission companies include BioComp Pharma, Inc., a generic drug marketer; ProSolus, Inc., a transdermal drug developer and manufacturer; Espada Dermatology, Inc., a prescription and esthetic dermatology company; as well as BexR Logistix, LLC and their subsidiary company, EPIC Fulfillment, Inc., the logistics and fulfillment arms of Mission. To learn more, please visit www.missionfamilyofcompanies.com.
# # #
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c799dcc2-28a9-4a5a-ba31-c243ea60be8b
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/0e77db05-7e11-4d68-a090-55e47903fdab
Drew Deeter DeeterUSA 215.348.3890 [email protected]


Washington Post Publisher Will Lewis Steps Down After Layoffs
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 



